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Abstract
We propose a dynamical system of tumor cells proliferation based on operatorial
methods. The approach we propose is quantum-like: we use ladder and number
operators to describe healthy and tumor cells birth and death, and the evolution is
ruled by a non-hermitian Hamiltonian which includes, in a non reversible way, the
basic biological mechanisms we consider for the system. We show that this approach
is rather efficient in describing some processes of the cells. We further add some
medical treatment, described by adding a suitable term in the Hamiltonian, which
controls and limits the growth of tumor cells, and we propose an optimal approach
to stop, and reverse, this growth.
I Introduction
In the past few years several macroscopic dynamical systems have been discussed using
quantum tools. This approach has been considered by many authors and the range of its
applications is wide, and has been successfully applied to various fields of sociology and
decision making processes [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], biology [15, 16], ecology
[17, 18, 19] economics [20, 21, 22], population and crowd dynamics [23, 24, 25, 26, 27], etc.
More applications of quantum ideas outside a standard quantum realm can be found, for
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instance, in the monographs [28, 29, 30, 31, 32, 33], and in many of the references cited
there.
Even if the underlying idea is shared among several authors (quantum ideas can be
used not only in quantum mechanics!), our specific approach often differs from that of
other authors. In particular, we use ladder operators of different kind (bosonic, fermionic,
or generalizations of these) to construct an Hamiltonian operator H for a certain system
S, and then we use H to deduce the time evolution of the observables of S, using the
Heisenberg or the Schro¨dinger equations of motion. H is constructed following a set of
minimal rules described in [33], and contains all the interactions occurring between the
different agents of S. In most of the cases considered so far, the Hamiltonian H is assumed
to be hermitian: H = H†. This allows us to use many standard results of ordinary
quantum mechanics. For instance, if an observable X of S, i.e. an hermitian operator
acting on the Hilbert space H where the system is defined, does not depend on the time
explicitly, then X(t) is a constant of motion, X(t) = X(0), for all t ≥ 0, if X commutes
with H. This is because, in the Heisenberg representation, X(t) = eiHtX(0)e−iHt, and
this coincides with X(0) if [H,X] = HX −XH = 0.
Sometimes, for some specific application, it is convenient to give up hermiticity of
H, and to work with some effective Hamiltonian Heff , with Heff 6= H†eff . This is what
happens quite often, for instance, in quantum optics and in PT-quantum mechanics,
[34, 35, 36, 37, 38]. In applications to macroscopic systems, as those which are relevant
for this paper, some sort of effective Hamiltonians was introduced, for instance in [18] and
in [17], to describe stress and positive effects in specific ecological systems. This choice
proved to be quite efficient in concrete computations, and is based on the introduction of
some imaginary parts in the parameters of the (otherwise hermitian) Hamiltonian of the
system. The sign of these imaginary parts is crucial in the modelization procedure. This
is not the only possibility to transform an hermitian Hamiltonian into a non-hermitian
one. For instance, if a1 and a2 are any two operators relevant in the description of S, an
hermitian term contributing to H could be a1a
†
2 + a2a
†
1. This, if aj are ladder operators,
represents a reversible exchange between, say, agent 1 and agent 2, see [33]. If we want to
make this exchange irreversible, the natural choice is to replace the previous sum with a
single term, a1a
†
2 for instance: agent 1 is giving something to agent 2, but not viceversa.
In this way we clearly loose hermiticity of the Hamiltonian, but we gain in its explicit
interpretation. This is exactly the kind of generalization we will adopt here, in the context
of cellular division, following and extending the original approach proposed in [16], where
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ladder operators were also used for a similar problem. In particular we will introduce a
manifestly non-hermitian Hamiltonian H describing the formation, the proliferation, and
the treatment of a tumor, and we will analyze the time evolution of some sort of number
of the healthy and sick (tumor) cells. More in details, the basic mechanisms considered in
our analysis are the following: (1) an healthy cell becomes sick (because of the presence
of some degenerative factor); (2) tumor cells multiply; (3) healthy cells multiply as well,
but not at the same rate. This is because the sick cells, in a realistic tumor evolution,
have a faster multiplication dynamics than that of healthy cells; (4) some treatment for
the disease begins. In particular, we will be interested to the effect of the treatment,
to its specific nature, and to the instant in which the treatment begins. Notice that
our model is mainly thought to describe some system in vitro, rather than real patients.
For this reason we will restrict our numerical computations to a reasonable, but not too
large, number of cells for the system. This is important to keep the computational time
under control. It is also important to stress that in this paper we will not compare the
performance of our with those of other existing models. A similar comparison is surely
important, but it is not so relevant for us, here; we are more interested in showing that
an interesting model can be constructed by using operators, rather than functions, and
quantum-like equations of motion.
The paper is organized as follows: in the next section we introduce the ladder operators
needed in our model. We will focus on some basic facts concerning these operators. They
were never used before, in our knowledge, in this kind of applications. In fact, they
are neither bosonic nor fermionic, in general, with a dimensionality which is directly
connected with the number of cells of our systems. In Section III we will introduce the
Hamiltonian H of the system, and deduce the dynamics out of H. Section IV is devoted
to our simulations, while our conclusions are contained in Section V.
II The ladder and the density operators
In many of the applications of quantum ideas to the macroscopic realm, the ladder oper-
ators which have been adopted were essentially of two kinds: bosonic or fermionic. This
means that our system may have either an infinite number of different conditions (the
various eigenstates of the bosonic number operator), or just two1. These two cases have
been enough to discuss many different applications so far. But, in some cases, it is more
1This is because the fermionic number operator has just two eigenstates.
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convenient to consider some intermediate situation. This is what was done, for instance,
in [39], in a different context.
Here we show how to construct ladder operators for a finite-dimensional Hilbert space
HN , with N <∞. In particular, the interesting case for us is N 6= 2, since, when N = 2,
ladder operators are very well known. For concreteness we will consider in details the
construction for N = 5, and then we will briefly comment on its generalization to other
N .
Let E5 = {ej, j = 0, 1, 2, 3, 4} be the canonical orthonormal (o.n.) basis of H5:
〈ej, el〉 = δj,l, j, l = 0, 1, 2, 3, 4, and eT0 = (1, 0, 0, 0, 0), eT1 = (0, 1, 0, 0, 0) and so on.
Here eTj is the transpose of ej. We define an operator b
† via its action on the ej’s:
b†e0 = e1, b†e1 =
√
2 e2, b
†e2 =
√
3 e3, b
†e3 =
√
4 e4, b
†e4 = 0 (2.1)
We see that b† behaves as a sort of fermionic raising operator, destroying the upper level.
Then, the matrix expression for b† in the basis E5 is the following:
b† =

0 0 0 0 0
1 0 0 0 0
0
√
2 0 0 0
0 0
√
3 0 0
0 0 0
√
4 0
 .
Hence its adjoint is
b =

0 1 0 0 0
0 0
√
2 0 0
0 0 0
√
3 0
0 0 0 0
√
4
0 0 0 0 0
 .
These operators look like the truncated versions of the raising and lowering bosonic oper-
ators. Of course, we cannot expect that they satisfy the canonical commutation relation
[b, b†] = 1 5, 1 5 being the identity operator in H5, since this would only be possible in an
infinite-dimensional Hilbert space. In fact, straightforward computations show that
[b, b†] = 1 5 − 5P4, (2.2)
where P4 is the projection operator on e4: P4f = 〈e4, f〉 e4, for all f ∈ H5. Notice that
1 5 − 5P4 is the following diagonal matrix: 1 5 − 5P4 = diag{1, 1, 1, 1,−4}, which differs
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from the identity matrix onH5 only for the last component in its main diagonal. b behaves
as a lowering operator:
be0 = 0, be1 = e0, be2 =
√
2 e1, be3 =
√
3 e2, be4 =
√
4 e3, (2.3)
as expected. Nˆ = b†b = diag{0, 1, 2, 3, 4} is the number operator, while Nˆs = b b† =
diag{1, 2, 3, 4, 0} is a sort of shifted version of N , but with a clear difference in the last
entry. They satisfy the following eigenvalue equations:
Nˆek = kek, Nˆsek =
{
(k + 1)ek, k = 0, 1, 2, 3
0, k = 4,
(2.4)
k = 0, 1, 2, 3, 4. It is easy to see that b5 = (b†)5 = 0.
It is clear how to extend the construction to N 6= 5. It is enough to consider the
canonical o.n. basis for HN , EN , and use its vectors to define b† in analogy with (2.1).
Then b is just the adjoint of b†. These are ladder operators such that b e0 = 0 and
b†eN = 0, and can be used to define Nˆ and Nˆs as above.
Remark:– If N = 2 formula (2.2) should be replaced by [b, b†] = 1 2 − 2P1 =
diag{1,−1}. Also b =
(
0 1
0 0
)
and b† =
(
0 0
1 0
)
, which is in agreement with the
well known expressions for the fermionic ladder operators.
In what follows, we will use this strategy to construct three different families of ladder
operators, one for each agent of the biological model we want to describe. Then we will
put all these ingredients together, by taking a suitable tensor product, in order to have
a common functional framework. More in details: the agents of the system S are the
healthy cells, attached to the ladder operators h and h†, living in an Hilbert space Hh.
Then we have the sick cells, described in terms of the ladder operators s and s†, defined
on Hs, and the medical treatment (m and m†, acting on Hm). We call Nα = dim(Hα),
where α = h, s,m. The o.n. basis of Hα is Eα = {e(α)j , j = 0, 1, 2, . . . , Nα − 1}. The
operators h, s and m satisfy relations which extend those above. First of all we have
h e
(h)
0 = 0, s e
(s)
0 = 0, m e
(m)
0 = 0, (2.5)
and then
e
(h)
1 = h
†e(h)0 , e
(h)
2 =
1√
2
h†e(h)1 , . . . , e
(h)
Nh−1 =
1√
Nh − 1
h†e(h)Nh−2, (2.6)
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e
(s)
1 = s
†e(s)0 , e
(s)
2 =
1√
2
s†e(s)1 , . . . , e
(s)
Ns−1 =
1√
Ns − 1
s†e(s)Ns−2, (2.7)
and
e
(m)
1 = m
†e(m)0 , e
(m)
2 =
1√
2
m†e(m)1 , . . . , e
(m)
Nm−1 =
1√
Nm − 1
g†e(m)Nm−2. (2.8)
Finally, we have that
h†e(h)Nh−1 = 0, s
†e(s)Ns−1 = 0, m
†e(m)Nm−1 = 0. (2.9)
The Hilbert space of our system is now the tensor product H = Hh⊗Hs⊗Hm, whose
dimension is clearly N = Nh × Ns × Nm. Each operator Xh on Hh is identified with
the following tensor product on H: Xh ⊗ 1 s ⊗ 1m, where 1 s and 1m are the identity
operators on Hs and Hm, respectively. Analogously, the operators Xs and Xm on Hs and
Hm should be identified respectively with 1 h ⊗Xs ⊗ 1m and with 1 h ⊗ 1 s ⊗Xm, where
we have introduced 1 h, the identity operator on Hh. Furthermore
(Xh ⊗Xs ⊗Xm) (fh ⊗ fs ⊗ fm) = (Xhfh)⊗ (Xsfs)⊗ (Xmfm),
for all fh ∈ Hh, fs ∈ Hs and fm ∈ Hm. From now on, when no confusion arises, we will
just write Xh, Xs, Xm instead of Xh ⊗ 1 s ⊗ 1m, 1 h ⊗ Xs ⊗ 1m and 1 h ⊗ 1 s ⊗ Xm, and
their action is obviously intended on the whole H.
An o.n. basis for H is the following:
E = {ϕnh,ns,nm := e(h)nh ⊗ e(s)ns ⊗ e(m)nm , nα = 0, 1, . . . , Nα − 1, α = h, s,m} ,
so that any state Ψ of the system S can be expressed as a combination of these vectors:
Ψ =
∑
nh,ns,nm
cnh,ns,nmϕnh,ns,nm . (2.10)
Here the sum is extended to all the possible values of nh, ns and nm, and cnh,ns,nm
are complex scalars not necessarily chosen to normalize Ψ in the conventional way,∑
nh,ns,nm
|cnh,ns,nm |2 = 1: we will not necessarily assume that ‖Ψ‖ = 1. The reason
is that, even if ‖Ψ‖ = 1 for t = 0, it is no longer so, in general, for t > 0, due to the fact
that our time evolution is not unitary, as we will show later.
Each of the elements of E can be easily interpreted. For instance, ϕnh,0,0, with nh > 0,
describes a situation in which the system consists only of healthy cells, with no sick cell
and with no active medical treatment, whereas ϕn,2n,1, with n > 0, represents a state in
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which the sick cells are twice the number of the healthy ones, and a medical treatment is
acting. A simple computation shows that all the ladder operators of the different agents
commute: [Xs, Xm] = 0, and so on. For instance, using the properties of the tensor
product, we see that
[h,m]ϕnh,ns,nm = h e
(h)
nh
⊗ e(s)ns ⊗me(m)nm − h e(h)nh ⊗ e(s)ns ⊗me(m)nm = 0.
From the ladder operators we have constructed we can derive observables useful to
quantify the number of healthy and sick cells, and to deduce the general condition of the
system.
In particular we first define, see (2.4):
Nˆh = h
†h, Nˆs = s†s, Nˆm = m†m, (2.11)
which act on the elements of E as follows:
Nˆhϕnh,ns,nm = nhϕnh,ns,nm , Nˆsϕnh,ns,nm = nsϕnh,ns,nm , Nˆmϕnh,ns,nm = nmϕnh,ns,nm .
(2.12)
Following the general scheme proposed in [33]. these operators will be used to measure
the number of specific cells of the system and to check is the medical treatment is active
or not. For that we introduce, following [40] and [41], the following expectation values
over the normalized state of the system:
〈Nˆh〉 =
〈
Ψ
‖Ψ‖ , Nˆh
Ψ
‖Ψ‖
〉
=
∥∥∥∥h Ψ‖Ψ‖
∥∥∥∥2 , (2.13)
〈Nˆs〉 =
〈
Ψ
‖Ψ‖ , Nˆs
Ψ
‖Ψ‖
〉
=
∥∥∥∥s Ψ‖Ψ‖
∥∥∥∥2 , (2.14)
〈Nˆm〉 =
〈
Ψ
‖Ψ‖ , Nˆm
Ψ
‖Ψ‖
〉
=
∥∥∥∥m Ψ‖Ψ‖
∥∥∥∥2 , (2.15)
where 〈·, ·〉 is the scalar product in H and ‖·‖2 = 〈·, ·〉. 〈Nˆh〉 and 〈Nˆs〉 count the number
of healthy and sick cells in the system, while 〈Nˆm〉 indicates whether a medical treatment
is active on S, or not. It is easy to show that, for instance, 〈Nˆh〉 ≤ Nh − 1:
0 ≤ 〈Nˆh〉 =
∑
nh,ns,nm
nh|cnh,ns,nm|2∑
nh,ns,nm
|cnh,ns,nm |2
≤
∑
nh,ns,nm
(Nh − 1)|cnh,ns,nm|2∑
nh,ns,nm
|cnh,ns,nm|2
= Nh − 1.
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Hence 〈Nˆh〉 always returns a finite measure of the expected number of healthy cells, which
does not exceed the maximum value Nh−1. Similar considerations lead to the inequalities
〈Nˆs〉 ≤ Ns − 1 and 〈Nˆm〉 ≤ Nm − 1.
It is useful to introduce the following density-like operators:
Pˆh =
∑
nh,nm
|ϕnh,0,nm〉〈ϕnh,0,nm|, Pˆs =
∑
ns,nm
|ϕ0,ns,nm〉〈ϕ0,ns,nm|, (2.16)
where |g〉〈h|, g, h ∈ H, is the rank one operator which acts on any f ∈ H as (|g〉〈h|)f =
〈h, f〉 g. The operator Pˆh projects the state of the system in a subspace of H in which
there are no tumor cells (the quantum number for the sick cells is ns = 0), a healthy
state. For instance, if the state Φh of the system is a superposition of only healthy states,
Φh =
∑
nh,nm
cnh,nmϕnh,0,nm , we have PˆhΦh = Φh, whereas if we consider a superposition
of only sick states, Φs =
∑
nh,ns>0,nm
cnh,ns,nmϕnh,ns,nm , then PˆhΦs = 0. Hence we use this
operator to obtain a probabilistic measure of the presence of only healthy cells trough the
expectation value
〈Pˆh〉 =
〈
Ψ
‖Ψ‖ , Pˆh
Ψ
‖Ψ‖
〉
=
∑
nh,nm
∣∣∣∣〈ϕnh,0,nm , Ψ‖Ψ‖
〉∣∣∣∣2 , (2.17)
computed over the normalized state of the system. Straightforward computations give
0 ≤ 〈Pˆh〉 =
∑
nh,nm
|cnh,0,nm|2∑
nh,ns,nm
|cnh,ns,nm |2
≤ 1,
which motivates why we can assign to 〈Pˆh〉 the probabilistic interpretation suggested
above. Analogously, Pˆs projects the state in a sick superposition, (the quantum number
of the healthy cells is nh = 0). The expectation value
〈Pˆs〉 =
〈
Ψ
‖Ψ‖ , Pˆs
Ψ
‖Ψ‖
〉
=
∑
ns,nm
∣∣∣∣〈ϕ0,ns,nm , Ψ‖Ψ‖
〉∣∣∣∣2 =
∑
nh,nm
|c0,ns,nm|2∑
nh,ns,nm
|cnh,ns,nm|2
, (2.18)
satisfies the inequality 0 ≤ 〈Pˆs〉 ≤ 1, and for this reason can be considered as the proba-
bility to have only tumor cells in S.
Extending formulas (2.13)-(2.15) above for the positive hermitian operators Nˆh, Nˆs
and Nˆm to a generic, not necessarily hermitian operator Oˆ, we introduce here∣∣∣〈Oˆ〉∣∣∣ = ∣∣∣∣〈 Ψ‖Ψ‖ , Oˆ Ψ‖Ψ‖
〉∣∣∣∣ , (2.19)
which will be used in the following to get some interesting information on the system2.
2Of course, if Oˆ coincides, say, with Nˆh, (2.19) coincides with (2.13).
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III The Hamiltonian of the system
We have introduced before the main ingredients of our system S: the healthy (h) and
the sick (s) cells, and the medical treatment (m). Notice that, compared with [16], we
are not inserting here any factor which causes the transition of a cell from a healthy to
a sick state, while we are considering explicitly some medical treatment which should
contrast the sickness. The reason for not inserting any carcinogenic factor is that we
are already assuming that this transition occurs, and this implies the presence of such
a factor, which needs not to be considered as a dynamical variable of S. This has nice
consequences on the dimensionality of our Hilbert space, which is somehow lowered by
this choice, improving in this way the computational time. We are much more interested
in discussing the changes in the reaction of the tumor cells depending on when and how
the medical treatment we consider acts on S. We will discuss this aspect in many details
in Section IV.
The mechanisms which we imagine in S are the following: first of all, healthy cells
become sick (h→ s). Secondly, these sick cells multiply by mitosis (s→ s+ s). Healthy
cells multiply too, but possibly with a lower frequency (h→ h+h). We also imagine two
different kind of medical treatments: in the first one, the medicine disappears during the
treatment which destroys a sick cell (s + m→ ∅). In the second treatment the medicine
acts but it does not disappear: s + m → m. The first is when, for instance, the medical
treatment is active only for some time, and then is removed, while the second is more
connected to some continuous (in time) treatment. We will see that the second treatment
is much more efficient than the first one, which turns out to be not particularly useful, in
the long run.
As usual, all these mechanisms will be encoded by a suitable Hamiltonian H. However,
modifying the standard approach, [33], the Hamiltonian which we propose is manifestly
not hermitian. And, as we have discussed in the Introduction, the lack of hermiticity
will not be caused by the presence of some complex-valued parameter in H, but by the
absence of some hermitian conjugate terms in the Hamiltonian itself. To be more explicit,
we first introduce the following operator:
H˜ = H˜0 + H˜I + H˜g
H˜0 = ωhNˆh + ωsNˆs + ωmNˆm,
H˜I = µhs(hNˆhs
† + sNˆhh†) + µhh(h†Nˆh + Nˆhh) + µss(s†Nˆs + Nˆss),
H˜m = µsm1(sNˆsm+m
†Nˆss†) + µsm2(sNˆs + Nˆss
†)Nˆm,
(3.1)
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where the parameters ωα and µαβ are assumed to be real and, for the moment, time
independent. Hence H˜ = H˜†. The meaning of H˜0 is well understood, [33]: first of all,
it creates no interesting dynamics when all the µ’s are zero. In fact, in this case, Nˆh,
Nˆs and Nˆm commute with H˜, and therefore they all stay constant in time. This means
that, for instance, if we start with a situation where there are no cancer cells, then their
number remains zero for all t ≥ 0. However, when some of the µ’s are different from zero,
the values of the ωα describes a sort of inertia of the agent α: the larger this value, the
smaller the variations of the mean value of the related number operator. This effect was
observed in several applications, see [33].
The first part of the first term in H˜I , hNˆhs
†, describes the mutation of healthy into
sick cells. This is because one healthy cell is destroyed by h and a sick cell is created by s†.
Of course this mutation is more probable when S is made of many healthy cells, and this
explains the appearance of the number operator Nˆs, which works by counting the number
of healthy cells. Its hermitian conjugate, sNˆhh
†, describes the opposite transition, from a
cancer to a healthy cell. It is clear that this effect is like a spontaneous healing, which is
quite unexpected and not well recognized from a biological point of view.
Something similar can be repeated for the other terms in H˜I and for those in H˜m: the
terms h†Nˆh and s†Nˆs describe duplications of the healthy and of the sick cells, respectively.
This duplication can only occur, of course, if some cell of that particular kind already
exists, and is more frequent if these cells are many. This is modelled by the presence of Nˆh
and Nˆs in the Hamiltonian, respectively. Of course, since we expect that the duplication
is faster for the sick rather than for the healthy cells, it is natural to take µhh < µss.
Once again, their hermitian conjugates Nˆhh and Nˆss are biologically strange. In fact,
they would correspond to the death of the healthy and of the cancer cells. This could
be understood as the effect of age, for instance, or, again, of some spontaneous healing,
but in any case it is quite strange to imagine that the, say, cancer cells are created and
destroyed in S at the same rate.
Similar difficulties arise also when trying to interpret H˜m. The term sNˆsm describes
the death of sick cells as a consequence of some medicinal treatment, which disappears
after being used. Similarly, sNˆsNˆm describes the death of sick cells, but the treatment
stays active since m is replaced by Nˆm. As stated above, these two terms reflects two
different possible treatments of the disease. But Hm also contains two terms which are not
quite natural, but are needed if we want to work with hermitian Hamiltonians: m†Nˆss†
describes a situation in which, in presence of medicine, both the number of cancer cells
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and the amount of medicine increase. It is like if the system evolves backward in time.
And the same could be deduced from s†NˆsNˆm: the number of sick cells increases, even if
the medical treatment is active.
We conclude that, also if some of the contributions above can be somehow motivated,
this motivation is not always really satisfying and induces biological effects not easy to
understand or not observed in real tumoral growth. For this reason, in this paper, we are
considering the possibility to work with a non-hermitian Hamiltonian, extracting from H˜
only those terms which are meaningful, and reasonable, from a purely biological point of
view. This is, in fact, a big innovation with respect to what was done so far, in similar
contexts.
This suggests to define the following Hamiltonian:
H = H0 +HI +Hg
H0 = ωhNˆh + ωsNˆs + ωmNˆm,
HI = µhshNˆh
(
s† + PˆNs
)
+ µhhh
†Nˆh + µsss† Nˆs,
Hm = µsmsNˆs Nˆm.
(3.2)
Remark:– With respect to H˜m, in Hm we are not considering µsm1sNˆsm, that is we
are neglecting the possibility of using medicines which disappear during the treatment.
The reason is that our numerical investigations gave evidence that this term does not really
modify the dynamics of the system. This can be mathematically understood because of
the presence of m in the term above: the (repeated) action of m over a generic vector
of S destroys the state! From the point of view of its biological interpretation, it is like
if the medicine stays active just for a while, and then it is consumed. It is clear that
this approach cannot be particularly efficient, compared with a different (continuous)
treatment. This is exactly what our simulations show. For this reason, we only consider
only the second treatment, and, to simplify the notation, we put µsm = µsm2 .
Notice that HI contains a correction to the original mutation term hNˆhs
† in (3.1),
based on the following operator:
PˆNs :=
√
Ns
∑
nh,nm
|ϕnh,Ns−1,nm〉〈ϕnh,Ns−1,nm |. (3.3)
The rationale for adding this term is the following: PNs has a non zero effect only on
those states whose expansion in terms of E contains some vector ϕnh,Ns−1,nm . Otherwise its
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action is trivial. In particular we see that, while s†ϕnh,Ns−1,nm = 0, (s
†+PNs)ϕnh,Ns−1,nm =
ϕnh,Ns−1,nm . This is useful to describe a sort of equilibrium when the maximum number of
sick cells is reached, avoiding to destroy the system completely during the time evolution,
in this particular case: stated differently, if the cells of S are extremely sick, then they
stay sick!
The Hamiltonian (3.2) is manifestly non hermitian. This implies that we have to
impose some choice on how to derive the time evolution of the system. The reason for
this is the following: if H 6= H†, the Schro¨dinger and the Heisenberg equations are not
equivalent any more. This is widely discussed, for instance, in [33], and is mainly based on
the fact that the operator e−iHt is not unitary. The choice we adopt here is quite common,
for instance in quantum optics: we assume that, even if H 6= H†, the time evolution of
the wave function of S is still driven by the Schro¨dinger equation of motion
iΨ˙(t) = HΨ(t). (3.4)
Its solution is Ψ(t) = e−iHtΨ(0), where Ψ(0) is the initial state of the system. In our
case, Ψ(0) describes how many healthy and sick cells exist at t = 0, and if the medical
treatment is also active in the system or not, when the evolution starts. In general, Ψ(0)
can be expressed in terms of the vectors in E as in (2.10).
We assume from now that Nm = 1, which essentially means that the medical treatment
is a dichotomous variable: the eigenvalues of Nˆm can only be zero and one: absence or
presence of a medical treatment. In our computations we will always take Ns > Nh, since
the biology of cancer cells suggests that the sick cells are luckily to grow, in number, more
than the healthy ones. More explicitly, we fix Nh = 50 and Ns = 150, much less than
in real experimental settings. However, these values are a good compromise between a
realistic situation and a reasonable computational time.
III.1 Evolution of the system
We are now ready to derive the differential equations ruling the time evolution of S. To
simplify the notation we introduce, when possible, the vector ~n = (nh, ns, nm), nh =
0, . . . , Nh − 1, ns = 0, . . . , Ns − 1, nm = 0, 1 = Nm − 1. To determine the densities
, we need first to compute the time evolution of the state of the system. In particular,
let Ψ(0) =
∑
nh,ns,nm
c~n(0)ϕ~n be the initial state of the system, where the complex scalar
coefficients c~n(0) can be chosen to satisfy
∑
nh,ns,nm
|c~n(0)|2 = 1 (but not necessarily). In
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what follows we will always assume that c~n(0) = δ~n,~no , where ~n
o = (noh, n
o
s, n
o
m). This
means that, at t = 0, S is in a common eigenstate of the operators in (2.11) We have
already stressed that, due to the non hermiticity of our Hamiltonian (3.2), the evolution
is non unitary, so that, in general, ‖Ψ(t)‖ 6= ‖Ψ(0)‖ for t > 0
The time evolution of Ψ(0) is driven by the Schro¨dinger equation (3.4), where the time
dependence is all contained in the coefficients c~n, which therefore are functions of time,
c~n(t). Using the orthogonality conditions of the basis vectors ϕ~n, we obtain the following
system
i
dc~n(t)
dt
= 〈ϕ~n, HΨ(t)〉, ∀~n, (3.5)
which produces the following set of differential equations, ∀nh, ns, nm:
i
dcnh,ns,nm(t)
dt
=
(
ωhnh + ωsns + ωmnm
)
cnh,ns,nm +(
[nh < Nh − 1][ns > 0]µhs (nh + 1)
√
(nh + 1)nscnh+1,ns−1,nm +
[nh < Nh − 1][ns = Ns − 1]µhs(nh + 1)
√
(nh + 1)Nscnh+1,Ns−1,nm +[
nh > 0
]
µhh(nh − 1)√nhcnh−1,ns,nm +
[
ns > 0
]
µss(ns − 1)√nscnh,ns−1,nm
)
+([
ns < Ns − 1
]
µsmnm(ns + 1)
√
ns + 1cnh,ns+1,nm
)
,
where
[
•
]
is a logical operator returning 1 if • is true, and 0 otherwise.
This is a linear system of ordinary differential equations if all the parameters of H
are fixed. In this case, a solution can be easily deduced, in principle. However, what is
more interesting for us is to consider some of these parameters dependent on the density
of the (sick and/or healthy) cells. This is relevant for us, since it describes the fact
that the medication starts when the tumour has grown to a certain size, and not before,
possibly because its presence has not even be recognized. We are particularly interested
in analysing what happens when we modify this parameter, changing the instant in which
the medication starts, and its strength. In this case the above system becomes, in general,
nonlinear, since the parameters depend on the mean values of the number operators in
(2.13)-(2.15), and its solution is not so simple and needs to be computed numerically. In
particular, the numerical solutions we shall adopt in this work are obtained by using an
explicit Runge-Kutta formula based on the Dormand-Prince pair, [42], where densities in
(2.13)-(2.15) are computed at each time step.
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IV Numerical results
In this Section we present the numerical outcomes of our model. We consider two main
scenarios: absence and presence of medical treatment. And, in the latter scenario, we
propose different strategies.
In many simulations we fix the parameter µhs = 1 in (3.2), which is equivalent to fix
the time scale according to µhs. We always consider a time dependent production of the
healthy cells, assuming that this production degrades more and more in presence of higher
number of tumor cells. This reflects real phases of tumor cells proliferation, [43], which
removes vital space to the healthy cells. In particular we introduce a specific dependence
of µhh on 〈Nˆs〉, by choosing a logistic–like expression µhh(〈Nˆs〉) := µ˜hh
(
1− 〈Nˆs〉
Ns−1
)
. Here
µ˜hh is the maximum value assumed by µhh when no tumor cell is present, 〈Nˆs〉 = 0,
and µhh(〈Nˆs〉) decreases for increasing 〈Nˆs〉. Finally, recalling that the parameters ωh,s,m
measure the resistance of the system to change, [33], we make this resistance low by taking
very small values of them, ωh,s,m = 10
−2.
IV.1 No medical treatment
We start considering the scenario in which no medical treatment is active on S. This
implies that µsm = 0. We have considered first three different configurations, in which
µhs = 1, always: µss = 0.5, µ˜hh = 0.25 in the configuration R1, µss = 2, µ˜hh = 1 in
configuration R2, and µss = 0.125, µ˜hh = 0.0625 in configuration R3. Scenarios R1 and
R2 represent respectively situations in which the relevant effects are mutation of healthy
into sick cells (R1), and proliferation of tumor cells (R2). In R3, proliferation of both
tumor and healthy cells is a weak effect when compared to the mutation.
Initial conditions for all the simulations are 〈Nˆh〉 = Nh − 1, 〈Nˆs〉 = 0, corresponding
to Ψ(0) = ϕNh−1,0,0. This initial state consists in only healthy cells in the system. Of
course, the condition µsm = 0 implies that no medical treatment is active on S.
The outcomes in terms of number of healthy, 〈Nˆh〉, and tumor cells, 〈Nˆs〉, are shown
in Figure 1(a), while the probability of having only healthy, 〈Pˆh〉, or only tumor cells,
〈Pˆs〉, are shown in Figure 1(b). We observe different stages in the three scenarios. In a
first stage, as expected, the number of healthy cells decreases, as a consequence of their
mutation into tumor cells. This leads to a very fast decrease of the probability 〈Pˆh〉 of
having only healthy cells, which rapidly decreases to zero in a very small time interval
≈ 0.01, Figure 1(b). A second stage is mainly ruled by the proper proliferation of tumor
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cells by mitosis, with the further decay of the number of healthy cells. We can observe
the beginning of this second stage in Figure 1(a): at some specific time, depending on the
configuration considered, the number of tumor cells suddenly growths while the number
of healthy cells decreases. This is clearly visible at t ≈ 0.046, 0.11 for the configurations
R1 and R2. In the final stage the tumor cells saturate and essentially cover the whole
system, with an increasing probability of having only tumor cells, see Figure 1(b), while
the number of healthy cells tends asymptotically to zero.
The various stages described above can be conveniently understood by means of the
analysis of the expectation values of the various terms in the Hamiltonian (3.2). In par-
ticular, we compute as in (2.19) the moduli |〈Hhs〉|, |〈HhNˆh〉|, |〈HsNˆs〉| of the expectation
values related to the mutation term µhshNˆhs
†, and to the proliferation terms µhhh†Nˆh
and µsss
†Nˆs. Adapting to the present context the typical meaning associated to the ex-
pectation values in quantum mechanics, the higher these values, the more relevant are the
contributions of the related operators to the dynamics of the system. The time evolutions
of |〈Hhs〉|, |〈HhNˆh〉|, |〈HsNˆs〉| are shown in Figures 2(a)-2(b) for the configuration R1, R2,
respectively. The first stage is mainly governed by the dynamics induced by µhshNˆhs
†,
whereas the second stage is governed by the tumor cell mitosis induced by µsss
†Nˆs: this
effect is particularly evident in the configuration R2 where the value of the parameter µss
is higher than in R1. At the same time, we can observe the small effect induced by the
healthy cell mitosis contribution µhhh
†Nˆh. The last small increment in 〈Hhs〉 at t ≈ 1.3
and t ≈ 0.6 for the two configurations, is due to the increasing contribution of PˆNs defined
in (3.3). This contribution becomes relevant when 〈Nˆs〉 ≈ Ns− 1, which is the case when
the state Ψ(t) is essentially a combination of the states ϕnh,Ns−1,nm . At the same time
|〈HsNˆs〉| → 0, consistently with the fact the no other tumor cells are produced.
IV.2 Medical treatment I: time independent treatment
The three scenarios introduced before are mainly meant to show that our model can
efficiently describe a global mutation of healthy into sick cells. This mutation takes some
time, of course. The relevant aspect of the model, for us, is whether this process can be
stopped or, better, reversed, and how. This is why now we discuss what happens if µsm
is taken different from zero.
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Figure 1: (a) Number 〈Nˆh〉, 〈Nˆs〉 of healthy and tumor cells configurations R1, R2 and R3.
In the inset the magnification of the early time time evolutions of 〈Nˆh〉. (b) Probability
〈Pˆh〉 of having only healthy cells for the same scenarios. In the inset the large time
evolutions of the probability 〈Pˆs〉 of having only tumor cells .
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Figure 2: Time evolutions of the moduli |〈Hhs〉|, |〈HsNˆs〉|, |〈HhNˆh〉| for the configuration
R1 (a), and for the configuration R2 (b).
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First we consider the case in which the medical treatment starts from the beginning of
the evolution, with the further assumption that the parameter µsm is time independent.
Initial conditions and other parameters are the same used in configuration R1 considered
before. We show in Figures 3(a)-3(b) the time evolutions of the mean values 〈Nˆh〉, 〈Nˆs〉 of
healthy and tumor cells for different values of µsm. The results show that the action of a
medical treatment reduces 〈Nˆs〉 as the intensity of the treatment is increased, see Figure
3(b). This is exactly the result one should expect for biological reasons. Conversely, the
number 〈Nˆh〉 is no more asymptotically going to zero, as in absence of medical treatment,
see Figure 1(a), and it stabilizes (or oscillates) around a value which increases with µsm.
This is related to the fact that the tumor cells do not saturate the system, so that the
production of healthy cells, given by µhhh
†Nˆh, does no more vanish. S reaches a sort of
equilibrium between healthy and sick cells: neither the first, nor the second, completely
disappear from the system.
The intensity of the medical treatment during time is related to measure of the in-
tensity of µsmsNˆsNˆm, |〈Hsm〉|, shown in Figure 3(d). We observe that |〈Hsm〉| does not
increase with µsm at all time: several oscillations are observed, arising from the various
relations between the agents of the system. Notice that, for all values of µsm, |〈Hsm〉| is
much larger than |〈HhNˆh〉|, see Figures 3(c) and 3(d).
We observe that the probability 〈Pˆs〉 of having only tumor cells in the system is
always vanishing, reaching at most a value of order 10−7, well below what we have found
in absence of medical treatment, see Figure 1(b).
IV.3 Medical treatment II: time dependent treatment
We consider in this Section the possibility of introducing a time dependency in the action
of the medical treatment. In particular, we suppose that µsm can depend both on time
and on the number of the cells.
In the first configuration, called MT1, we assume that
µsm(t) =
M∑
k=1
A exp(− ((t− k)/σ)2), A, σ > 0, (4.1)
which corresponds to a variable intensity of the medical treatment having peaks at t =
1, 2, . . . ,M . Here M is the last value of t when the medical treatment is acting. Initial
conditions and other parameters are as in R1.
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Figure 3: Number 〈Nˆh〉 of healthy cells (a), number 〈Nˆs〉 of tumor cells (b), modulus
|〈HhNˆh〉| of the expectation value of the healthy cells production Hamiltonian (c) and
modulus |〈Hsm〉| of the expectation value of the medical treatment Hamiltonian (d),
during the medical treatment scenario for various values of the parameter µsm. Initial
conditions and other parameters are those used in configuration R1
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Results in terms of number of cells, and amplitude of |〈Hhs〉|, |〈HsNˆs〉|, |〈Hsm〉| are
shown in Figure 4(a) and Figure 4(c) for A = 2.5, σ = 0.25,M = 4. During the maximum
intensity of the medical treatment, at the peaks of µsm(t) and the consequent high value
of |〈Hsm〉|, the number of tumor cells suddenly decreases, with a simultaneous increment
of healthy cells. At the same time, the effect of the mutation of healthy into sick cells is
weakened, as one can easily deduce from the plot of |〈Hhs〉|, see Figure 4(c).
The second configuration, MT2, is based on a time-dependent choice of the parameter
µhs, which we assume behaves as follows: µhs(t) =
µ˜hs
1+µsm(t)
, that is we assume that when
the strength µsm(t) of the treatment increases, the mutation of healthy into tumor cells
decreases. Moreover we set µ˜hs = 1, µss = µhh = 1, while the initial conditions, the other
parameters and µsm(t) are the same specified for the configuration MT1. The results are
shown in Figure 4(b) and Figure 4(d). The treatment here has two effects: it destroys
tumor cells, and it reduces the mutation of healthy cells. Figure 4(d) shows that, when the
|〈Hsm〉| has its peaks, that is when the intensity of the Hamiltonian term Hsm is higher,
the number of healthy cells significantly grows. Comparing Figures 4(a) and 4(b) we also
see that configuration MT2 works better than MT1: more tumor cells are destroyed and
more healthy cells are created in correspondence of the peaks of µsm(t). However, we still
do not get complete healing.
For this reason, we consider a third scenario, MT3, in which a quasi-healthy state is
obtained, choosing properly some of the parameters of H. This healing is based on the
idea of controlling and limiting the mutation of the healthy cells and the proliferation of
tumor cells. We accomplish this by considering the following time dependent parameters:
µhs(t) = µ˜hsexp
(
−〈Nˆm〉Ns − 1− 〈Nˆs〉〈Nˆs〉
)
, (4.2)
µss(t) = µ˜ssexp
(
−〈Nˆm〉Ns − 1− 〈Nˆs〉〈Nˆs〉
)
, (4.3)
whereas µ˜hs, µ˜ss are fixed constants. In (4.2)-(4.3) µhs(t) and µss(t) depend on time only
when the medical treatment is acting (〈Nˆm〉 6= 0), and their amplitudes decreases when the
number of tumor cells is low (µhs(t), µss(t) ≈ 0 for 〈Nˆs〉 → 0): mutation and proliferation
of sick cells are small effects if 〈Nˆs〉 is small. But, when 〈Nˆs〉 increases, these mechanisms
become more and more relevant.
We present in Figure 5(a) the results of the numerical simulation of MT3 with initial
condition Ψ(0) = ϕ40,10,1, corresponding to 〈Nˆh〉 = 40, 〈Nˆs〉 = 10, µ˜hs = µ˜ss = 1, and
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µsm(t) and other parameters as in MT1. The evolutions of 〈Nˆh〉 and 〈Nˆs〉 clearly show
that the number of healthy cells increases whereas the number of tumor cells decreases,
with a non vanishing probability 〈Ph〉 that the system contains only healthy cells. The
main effect induced by the treatment is the overall control over the degeneracy of the
healthy cells and the mitosis of the tumor cells, which are now weak mechanisms when
compared to the normal proliferation of healthy cells. This can be deduced from the
time evolutions of |〈HhNˆh〉|, |〈Hhs〉|, |〈HsNˆs〉|, shown in Figure 5(b): |〈Hhs〉|, |〈HsNˆs〉| are
negligible with respect to |〈HhNˆh〉|, and tend to vanish together with the number of tumor
cells.
V Conclusions
In this paper, we have constructed an operatorial model for mutations of healthy into
tumor cells, focusing in particular on the possibility of reversing this transition. We
have proposed a modified version of the general strategy proposed in [33], based on a
non-hermitian Hamiltonian describing, in a non reversible way, several relevant biological
effect: mutation of healthy into tumor cells, proliferation by mitosis of all the cells, and
a medical treatment which acts to control and limit the proliferation of tumor cells. The
results have been presented in terms of numbers of cells and probability to have a pure
healthy or a pure sick state. Furthermore, we have explained the various stages of the
evolution of S in terms of mean values of the various terms appearing in the Hamiltonian.
We have first seen how, in absence of any medical treatment, the model describes well
the effect of the carcinogenic factor causing mutation of the cells. Then, we have seen
situations in which the effect of the treatment can partially reverse, or at least keep under
control, this mutation. Not surprisingly, the efficiency of the treatment is related to its
strength. We have shown that, within our model, a complete recovery of the system is
possible only when both the mutation of the healthy cells, and the mitosis of the tumor
cells, are properly controlled.
The model we have proposed, of course, is very basic, as it contains only few essential
mechanisms ruling the tumor growth. Many possible changes/improvements are possible.
For instance, one could consider a model with some spatial dependency. Moreover a
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Figure 4: Numbers 〈Nˆh〉 of healthy cells (a) and moduli |〈Hhs〉|, |〈HsNˆs〉|, |〈Hsm〉| of the
expectation values (b) for the time dependent configuration MT1. Numbers 〈Nˆh〉 of
healthy cells (c) and moduli |〈Hhs〉|, |〈HsNˆs〉|, |〈Hsm〉| of the expectation values (d) for
the time dependent configuration MT2. In both configurations, initial conditions are
those of R1. Other parameters are specified in the text.
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Figure 5: Configuration MT3. (a) Numbers 〈Nˆh〉, 〈Nˆs〉 of healthy and tumor cells. In the
inset the probability 〈Pˆh〉 of having only healthy cells in the system. (b) Time evolutions
of the moduli |〈HhNˆh〉|, |〈Hhs〉|, |〈HsNˆs〉| of the expectation values. In the inset we plot
the magnification of the early time evolution.
deeper analysis of the role of the starting time of the treatment is essential, in connection
with early diagnosis. More biologically motivated effects should further be inserted in the
Hamiltonian H, to make the model more realistic. For that, a comparison between our
results and biological finding would be essential.
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